Method for preparing haemophilus influenza quasi-human-derived carbohydrate chain based on skelemin Fn3

The invention belongs to the field of biotechnology and relates to a method for preparing haemophilus influenza Gal beta 1-4GlcNAc beta 1-3Gal beta 1-3GlcNAc quasi-human-derived carbohydrate chain based on human skelemin Fn3. The method comprises the steps of establishing a recombinant vector suitab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HAN LICHI, HU XUEJUN, ZHANG JIANING, DING NING, YANG YAN, YANG CHUNGUANG, SUN SHENXIA
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention belongs to the field of biotechnology and relates to a method for preparing haemophilus influenza Gal beta 1-4GlcNAc beta 1-3Gal beta 1-3GlcNAc quasi-human-derived carbohydrate chain based on human skelemin Fn3. The method comprises the steps of establishing a recombinant vector suitable for expression of escherichia coli K-12 series strain by comprehensively utilizing a haemophilus influenza lsg gene cluster lipopolysaccharide synthesis mechanism, a campylobacter jejuni pgl gene cluster N-carbohydrate chain synthesis mechanism, an escherichia coli in-vivo O antigen carbohydrate chain synthesis mechanism and a prokaryote transcriptional control mechanism; displaying the quasi-human-derived carbohydrate chain in escherichia coli by means of human-derived skelemin Fn3. The method has the advantages that fusion protein with the quasi-human-derived carbohydrate chain can be prepared easily, quickly and efficiently, and a foundation is provided for efficient low-cost large-scale preparation of quasi-